North America Continuous Ambulatory Peritoneal Dialysis Market Size and Forecast (2021

Description

List of Tables

The North America Continuous Ambulatory Peritoneal Dialysis Market is projected to reach US$ 634.6 Million by 2034, increasing from US$ 481.4 Million in 2025. The market is expected to expand at a CAGR of 3.1% from 2026 to 2034.

Executive Summary and North America Continuous Ambulatory Peritoneal Dialysis Market Analysis:

The North American continuous ambulatory peritoneal dialysis (CAPD) market is segmented into the United States, Canada, and Mexico. Increasing incidence of chronic kidney disease (CKD) and end-stage renal disease (ESRD) is creating sustained demand for renal replacement therapies. Major contributing factors include diabetes, hypertension, and population aging. CAPD provides an alternative to conventional in-center hemodialysis by enabling patients to receive treatment at home while maintaining greater independence and flexibility.

Technological progress in dialysis solutions, catheter design, transfer systems, and infection prevention has improved treatment safety and patient outcomes, supporting greater acceptance of CAPD. Established healthcare infrastructure and favorable reimbursement environments, particularly in the US and Canada, also improve access to home-based dialysis. CAPD can reduce the frequency of hospital and dialysis-center visits, making it an attractive option for healthcare systems focused on cost management and patient-centered care.

Greater awareness among patients and healthcare professionals is contributing to adoption, while government and healthcare initiatives promoting home treatment are creating additional momentum. The COVID-19 pandemic further highlighted the value of home-based therapies by reducing dependence on healthcare facilities and encouraging remote and decentralized treatment approaches. These factors are expected to support continued development of the North American CAPD market.

Strategic Insights

North America Continuous Ambulatory Peritoneal Dialysis Market Segmentation Analysis:

By Product Type, the North America Continuous Ambulatory Peritoneal Dialysis Market is segmented into Peritoneal Dialysis Solution, Peritoneal Dialysis Catheters, Peritoneal Dialysis Transfer Sets, and Others. The Peritoneal Dialysis Solution segment dominated the market in 2025.
By End User, the market is divided into In-Center Dialysis Settings and Home Care Settings. The In-Center Dialysis Settings segment held the largest market share in 2025.

Market Report Scope

North America Continuous Ambulatory Peritoneal Dialysis Market Outlook

The increasing global prevalence of chronic kidney disease is creating significant demand for renal replacement therapies, including continuous ambulatory peritoneal dialysis. According to the Global Burden of Disease (GBD) 2023 study, approximately 788 million adults aged 20 years and older were living with CKD in 2023, compared with 378 million in 1990. The study identified high blood glucose, elevated systolic blood pressure, and increased body mass index among important contributors to CKD-related disease burden.

In the United States, kidney disease represents a substantial healthcare challenge. Data from the Centers for Disease Control and Prevention and the National Institute of Diabetes and Digestive and Kidney Diseases indicate that more than one in seven US adults has CKD. The country also has a large population living with kidney failure who require dialysis or transplantation. The 2025 US Renal Data System Annual Data Report provides updated national information on CKD and ESRD populations, treatment modalities, and healthcare utilization.

CAPD offers an important home-based treatment option for suitable patients. Through regular manual exchanges of dialysis fluid, the therapy removes metabolic waste and excess fluid without requiring patients to travel to a dialysis center multiple times each week. This can provide greater flexibility and may help patients maintain employment, family activities, and other aspects of daily life.

The growing emphasis on home dialysis is also supporting the market. Healthcare providers and policymakers are increasingly exploring treatment models that provide patients with greater choice while managing the costs associated with facility-based dialysis. Continued improvements in catheter technology, dialysis formulations, infection-control practices, and patient education can further strengthen the suitability of CAPD.

As the number of people affected by advanced kidney disease continues to increase, the need for accessible, sustainable, and patient-centered dialysis options is expected to remain an important factor supporting the North American CAPD market.

North America Continuous Ambulatory Peritoneal Dialysis Market Country Insights

By country, the North America Continuous Ambulatory Peritoneal Dialysis Market is segmented into the United States, Canada, and Mexico. The United States held the largest market share in 2025.

The US has a substantial population requiring kidney replacement therapy, creating a strong underlying need for dialysis services. The USRDS maintains national data covering ESRD incidence, prevalence, treatment modalities, transplantation, mortality, and healthcare expenditures.

CAPD forms part of the broader peritoneal dialysis market and provides patients with a manually operated home-treatment alternative. Adoption of home dialysis has benefited from greater awareness of patient choice, improvements in clinical support, and efforts to expand access to decentralized treatment. Organizations are increasingly emphasizing education and support programs that help patients understand and manage home dialysis.

Recent industry developments have also focused on strengthening home dialysis infrastructure and improving digital support for patients and clinical teams. In October 2025, Vantive and US Renal Care announced a multi-year strategic agreement intended to expand home dialysis access and enhance patient and care-team support through digitally enabled peritoneal dialysis products and services. During 2025, Simergent also announced FDA 510(k) clearance for its Archimedes automated peritoneal dialysis system for patients with ESKD in clinical and home environments.

These developments reflect the broader movement toward technology-enabled home kidney care. Continued innovation, patient education, clinical support, and investment in home-treatment infrastructure are expected to create opportunities for the US CAPD market.

North America Continuous Ambulatory Peritoneal Dialysis Market Company Profiles

Key companies operating in the market include Terumo Corp, Medtronic Plc, Baxter International Inc, Advin Health Care Pvt Ltd, Fresenius Medical Care AG & Co KGaA, Utah Medical Products Inc, JMS Co Ltd, Polymedicure, Mitra Industries Pvt. Ltd., and Newsol Technologies Inc.

These companies are pursuing strategies including geographical expansion, product development, technological innovation, strategic collaborations, and mergers and acquisitions. Such initiatives are aimed at strengthening dialysis product portfolios, improving treatment technologies, expanding market reach, and responding to the growing demand for effective and patient-focused renal replacement solutions.

Product Code: TIPRE00044035

1. Executive Summary

1.1 Analyst Market Outlook

2. Global Continuous Ambulatory Peritoneal Dialysis Market Landscape

2.1 Overview
2.2 Value Chain Analysis
2.3 Supply Chain Analysis
- 2.3.1 List of Manufacturers/Suppliers
- 2.3.2 List of Potential Customers (Upto 50)
2.4 Porter's Five Forces Analysis
2.5 PEST Analysis

3. Competitive Landscape

3.1 Company Benchmarking by Key Players
3.2 Market Share Analysis, 2025 - By Key Players
3.3 Market Concentration

4. North America Continuous Ambulatory Peritoneal Dialysis Market - Key Industry Dynamics

4.1 Market Drivers
4.2 Market Restraints
4.3 Market Opportunities
4.4 Future Trends
4.5 Impact of Drivers and Restraints:

5. Continuous Ambulatory Peritoneal Dialysis Market - North America Analysis

5.1 North America Continuous Ambulatory Peritoneal Dialysis Market Revenue (US$ Million), 2021 - 2034
5.2 North America Continuous Ambulatory Peritoneal Dialysis Market Revenue Forecast and Analysis

6. North America Continuous Ambulatory Peritoneal Dialysis Market Revenue Analysis - by Product Type

6.1 North America Continuous Ambulatory Peritoneal Dialysis Market Forecast and Analysis by Product Type
- 6.1.1 Peritoneal Dialysis Solution
  - 6.1.1.1 Overview
  - 6.1.1.2 Peritoneal Dialysis Solution: North America Continuous Ambulatory Peritoneal Dialysis Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
- 6.1.2 Peritoneal Dialysis Catheters
  - 6.1.2.1 Overview
  - 6.1.2.2 Peritoneal Dialysis Catheters: North America Continuous Ambulatory Peritoneal Dialysis Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
- 6.1.3 Peritoneal Dialysis Transfer Sets
  - 6.1.3.1 Overview
  - 6.1.3.2 Peritoneal Dialysis Transfer Sets: North America Continuous Ambulatory Peritoneal Dialysis Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
- 6.1.4 Others
  - 6.1.4.1 Overview
  - 6.1.4.2 Others: North America Continuous Ambulatory Peritoneal Dialysis Market - Revenue and Forecast, 2021 - 2034 (US$ Million)

7. North America Continuous Ambulatory Peritoneal Dialysis Market Revenue Analysis - by End User

7.1 North America Continuous Ambulatory Peritoneal Dialysis Market Forecast and Analysis by End User
- 7.1.1 In-Center Dialysis Settings
  - 7.1.1.1 Overview
  - 7.1.1.2 In-Center Dialysis Settings: North America Continuous Ambulatory Peritoneal Dialysis Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
- 7.1.2 Home Care Settings
  - 7.1.2.1 Overview
  - 7.1.2.2 Home Care Settings: North America Continuous Ambulatory Peritoneal Dialysis Market - Revenue and Forecast, 2021 - 2034 (US$ Million)

8. North America Continuous Ambulatory Peritoneal Dialysis Market - Country Analysis

8.1 North America
- 8.1.1 North America Continuous Ambulatory Peritoneal Dialysis Market Forecast and Analysis - by Country
  - 8.1.1.1 United States Market
    - 8.1.1.1.1 United States: North America Continuous Ambulatory Peritoneal Dialysis Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
    - 8.1.1.1.2 United States: North America Continuous Ambulatory Peritoneal Dialysis Market - By Segmentation
      - 8.1.1.1.2.1 Product Type
      - 8.1.1.1.2.2 End User
  - 8.1.1.2 Canada Market
    - 8.1.1.2.1 Canada: North America Continuous Ambulatory Peritoneal Dialysis Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
    - 8.1.1.2.2 Canada: North America Continuous Ambulatory Peritoneal Dialysis Market - By Segmentation
      - 8.1.1.2.2.1 Product Type
      - 8.1.1.2.2.2 End User
  - 8.1.1.3 Mexico Market
    - 8.1.1.3.1 Mexico: North America Continuous Ambulatory Peritoneal Dialysis Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
    - 8.1.1.3.2 Mexico: North America Continuous Ambulatory Peritoneal Dialysis Market - By Segmentation
      - 8.1.1.3.2.1 Product Type
      - 8.1.1.3.2.2 End User

9 Continuous Ambulatory Peritoneal Dialysis Market Industry Landscape

10 - Key Company Profiles

10.1 Terumo Corp
- 10.1.1 Key Facts
- 10.1.2 Business Description
- 10.1.3 Products and Services
- 10.1.4 Financial Overview
- 10.1.5 SWOT Analysis
- 10.1.6 Key Developments
10.2 Medtronic Plc
- 10.2.1 Key Facts
- 10.2.2 Business Description
- 10.2.3 Products and Services
- 10.2.4 Financial Overview
- 10.2.5 SWOT Analysis
- 10.2.6 Key Developments
10.3 Baxter International Inc
- 10.3.1 Key Facts
- 10.3.2 Business Description
- 10.3.3 Products and Services
- 10.3.4 Financial Overview
- 10.3.5 SWOT Analysis
- 10.3.6 Key Developments
10.4 Advin Health Care Pvt Ltd
- 10.4.1 Key Facts
- 10.4.2 Business Description
- 10.4.3 Products and Services
- 10.4.4 Financial Overview
- 10.4.5 SWOT Analysis
- 10.4.6 Key Developments
10.5 Fresenius Medical Care AG & Co KGaA
- 10.5.1 Key Facts
- 10.5.2 Business Description
- 10.5.3 Products and Services
- 10.5.4 Financial Overview
- 10.5.5 SWOT Analysis
- 10.5.6 Key Developments
10.6 Utah Medical Products Inc
- 10.6.1 Key Facts
- 10.6.2 Business Description
- 10.6.3 Products and Services
- 10.6.4 Financial Overview
- 10.6.5 SWOT Analysis
- 10.6.6 Key Developments
10.7 JMS Co Ltd
- 10.7.1 Key Facts
- 10.7.2 Business Description
- 10.7.3 Products and Services
- 10.7.4 Financial Overview
- 10.7.5 SWOT Analysis
- 10.7.6 Key Developments
10.8 Polymedicure
- 10.8.1 Key Facts
- 10.8.2 Business Description
- 10.8.3 Products and Services
- 10.8.4 Financial Overview
- 10.8.5 SWOT Analysis
- 10.8.6 Key Developments
10.9 Mitra Industries Pvt. Ltd.
- 10.9.1 Key Facts
- 10.9.2 Business Description
- 10.9.3 Products and Services
- 10.9.4 Financial Overview
- 10.9.5 SWOT Analysis
- 10.9.6 Key Developments
10.10 Newsol Technologies Inc.
- 10.10.1 Key Facts
- 10.10.2 Business Description
- 10.10.3 Products and Services
- 10.10.4 Financial Overview
- 10.10.5 SWOT Analysis
- 10.10.6 Key Developments

11. Appendix

11.1 Glossary
11.4 Research Methodology and Approach
- 11.4.1 Secondary Research
- 11.4.2 Primary Research
- 11.4.3 Market Estimation Approach
  - 11.4.3.1 Supply Side Analysis
  - 11.4.3.2 Demand Side Analysis
- 11.4.4 Research Assumptions and Limitations
- 11.4.5 Currency Conversion
11.5 About The Insight Partners
11.6 Market Intelligence Cloud